Dysferlin‐null mice did not show increased atherosclerosis when on an ApoE‐deficient background, despite extensive muscle cell death [34], whereas dysferlin‐deficient patients show no major differences in early cardiorespiratory outcomes [8]. This evidence concerns the gene DYSF and atherosclerosis.